About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Staccato® Granisetron Multiple Dose PK | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT04327765

Staccato® Granisetron Multiple Dose PK

To examine the tolerability and safety of AZ-010 following 7 days of dosing (up to 3 mg) in healthy volunteers To characterize the pharmacokinetics of AZ-010 following 7 days of dosing (up to 3 mg) in...

Lead sponsor: Alexza Pharmaceuticals, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Alexza Pharmaceuticals, Inc.

Collaborators

Celerion

A Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetic Profile of Staccato Granisetron (AZ-010) in Healthy Volunteers

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy based on a medical evaluation including history, physical examination, vital signs, electrocardiograms (ECGs) and laboratory tests assessed at the screening visit and prior to the first dose of study drug.
•Body weight ≥ 50 kg and BMI within the range of 18 to 32 kg/m2, inclusive, at screening.
•Negative urine tests for selected drugs of abuse and alcohol breath test at screening and Day 1.

Exclusion Criteria

•Any significant medical condition

Related studies

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

Sodium vs Potassium Education to Improve Vascular Health

NCT07221448 · Healthy

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 30, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment30

Start dateMar 2020

Last updatedOct 30, 2020

Condition

Locations shown

Celerion

Tempe, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2020Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions